Cysteinylglycine
|
Basic information |
| Metabolite name | Cysteinylglycine |
 | HMDB0000078 |
 |
C01419 |
 |
439498 |
| Synonyms | L-Cysteinyl-glycine; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Cysteinylglycine |
| HMDB0000078 |
|
C01419 |
|
439498 |
| Synonyms | L-Cysteinyl-glycine; |
| No. of studies | 6 |
|
Relationship between Cysteinylglycine and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M181 | Type3 | venlafaxine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Ventral hippocampus | C57BL/6 J mouse | Up |
| Study M630 | Type2 | acupuncture + antidepressant group, post vs. before treatment | Urine | Human | Up |
| Study M651 | Type1 | LPS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M770 | Type4 | responder group vs. non-responder group | Serum | C57BL/6 mouse | Up |
| Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |